Delcath Systems reports plans to price public sale of common shares

Terrapin Opportunity helps to sell shares, funding corporate purposes

By Devika Patel

Knoxville, Tenn., Dec. 5 - Delcath Systems Inc. will price an offering of common stock with a 30-day greenshoe, according to a prospectus supplement filed Wednesday with the Securities and Exchange Commission.

Terrapin Opportunity, LP will buy the shares to resell to the public.

Proceeds will be used for general corporate purposes.

Delcath is based in Stamford, Conn., where it develops isolated perfusion technology for organ or region-specific delivery of therapeutic agents.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.